Revenue
2021
2022
2023
2024
2025
2026
Dr. Martens plc (DOCS)
Price£0.7200Cached quote
Net income
2021
2022
2023
2024
2025
2026
Free cash flow
2021
2022
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue | £764.9M | £787.6M | £877.1M | £1.00B | £908.3M | £773.0M |
| Gross profit | £506.0M | £511.7M | £575.2M | £618.1M | £578.8M | £470.5M |
| Gross margin | 66.15% | 64.97% | 65.58% | 61.79% | 63.72% | 60.87% |
| Operating expenses | £445.7M | £467.3M | £447.0M | £427.3M | — | — |
| Operating income | £60.3M | £44.4M | £128.2M | £190.8M | — | — |
| Operating margin | 7.88% | 5.64% | 14.62% | 19.07% | — | — |
| EBITDA | £127.7M | £110.5M | £196.3M | £235.0M | — | — |
| EBITDA margin | 16.69% | 14.03% | 22.38% | 23.49% | — | — |
| Net income | £23.8M | £4.5M | £69.2M | £128.9M | £181.2M | £34.7M |
| Net profit margin | 3.11% | 0.57% | 7.89% | 12.89% | 19.95% | 4.49% |
| Basic EPSper basic share | £0.03 | £0.01 | £0.07 | £0.13 | £0.18 | £0.04 |
| Diluted EPSper diluted share | £0.02 | £0.01 | £0.07 | £0.13 | £0.18 | £0.04 |